CROHNS DISEASE

This study looked at how safe the drug guselkumab is for people with moderate to severe Crohn's disease. 38 adults received the drug and were monitored for side effects and lab changes. The main goal was to track any health issues that came up during treatment.

This study followed 646 people with complex fistulas caused by Crohn's disease or other conditions to see how well standard surgeries work in real-world clinics. Researchers tracked whether fistulas closed and if complications occurred, but did not provide any new treatment. The …

This study tested a new drug called AZD7798 in 112 healthy volunteers and people with Crohn's disease. The main goal was to check if the drug is safe and how the body processes it. No treatment effects were measured, so this is an early safety-only study.

This study observed 92 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) in Switzerland who were taking vedolizumab either as an IV infusion or a shot under the skin. Researchers tracked which route patients chose and why, and how long they stayed on treatmen…